Moreover, we developed an algorithm based on serum BMP8A levels that showed an AUROC of 0.818 (p˂0.0001) to predict advanced fibrosis in NASH patients. The gene discussed is BMP8A; the disease is metabolic dysfunction-associated steatohepatitis.